Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience

ConclusionIn our retrospective analysis, upgrade patients had a higher risk of all-cause mortality thande novo patients, which might be attributable to their more significant comorbidity burden. The occurrence of lead dysfunction and pocket infections was more frequent in the upgrade group.
Source: Europace - Category: Cardiology Source Type: research